The global Burn Care Market, valued at US$2.46 billion in 2024, is projected to grow to US$3.35 billion by 2030, exhibiting a robust Compound Annual Growth Rate (CAGR) of 5.6%. This growth is attributed to rising burn injuries, advancements in treatment technologies, and increased awareness.
Among the product segments, biologics are expected to register the highest CAGR during the forecast period. This is driven by the increasing demand for advanced and effective treatment options for deep and complex burns, as biologics provide targeted healing and promote tissue regeneration.
Organogenesis Holdings Inc. is identified as a major player in this expanding market. The company's presence in the biologics segment positions it to capitalize on the strong and sustained growth anticipated for these advanced burn care solutions.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.